The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud.

Despite the fact that vaccines against COVID have already undergone strict safety reviews and that people continue to die ...